Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Landscape of Publicly Available Human Oral Microbiome Data.

Journal of dental research·2026
Same author

Outcome of Mid Trimester Termination of Pregnancy in Previous Caesarian Section By Combined Mifepristone and Misoprostol.

Mymensingh medical journal : MMJ·2026
Same author

Assessment of Serum Ferritin in Patients with Type 2 Diabetes Mellitus.

Mymensingh medical journal : MMJ·2025
Same author

Indigenous Australians' Oral Health Care Experiences: Recommendations for Culturally Safe Dental Care.

JDR clinical and translational research·2025
Same author

A Clinico-histopathological Correlation of Elective Abdominal Hysterectomy in a Tertiary Care Hospital of Bangladesh.

Mymensingh medical journal : MMJ·2025
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025

Related Experiment Video

Updated: Jun 6, 2026

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

Raised calcium promotes α-synuclein aggregate formation.

S Nath1, J Goodwin, Y Engelborghs

  • 1Biomolecular Dynamics, Katholieke Universiteit Leuven, Leuven, Belgium.

Molecular and Cellular Neurosciences
|December 15, 2010
PubMed
Summary
This summary is machine-generated.

Calcium significantly accelerates alpha-synuclein aggregation, a key process in Parkinson's disease. This study shows calcium promotes alpha-synuclein clumping in vitro and in cells, highlighting calcium's role in disease pathology.

More Related Videos

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
08:24

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

Area of Science:

  • Biochemistry
  • Neuroscience
  • Cell Biology

Background:

  • Parkinson's and Parkinson's-plus diseases are linked to abnormal alpha-synuclein protein aggregation.
  • The precise mechanisms driving alpha-synuclein aggregation are not fully understood.
  • Calcium ions are known to influence protein structure and function.

Purpose of the Study:

  • To investigate the effect of calcium on alpha-synuclein aggregation in vitro and in vivo.
  • To determine the role of calcium concentration and flux in promoting alpha-synuclein aggregation.
  • To explore the potential involvement of surface adsorption in calcium-dependent aggregation.

Main Methods:

  • In vitro studies using fluorescently labeled monomeric alpha-synuclein incubated with varying calcium concentrations.
  • Techniques employed: fluorescence microscopy, fluorescence correlation spectroscopy, and scanning electron microscopy.
  • Cell culture experiments using human 1321N1 cells expressing alpha-synuclein-GFP, with induced intracellular calcium increases.

Main Results:

  • Calcium accelerated alpha-synuclein aggregation on surfaces and in free solution in a dose-dependent manner.
  • Surface aggregates formed at low calcium concentrations (half-maximal at 80 μM), while soluble oligomers formed at higher concentrations (half-maximal at 180 μM).
  • Transient increases in intracellular calcium significantly enhanced cytoplasmic alpha-synuclein aggregation in cultured cells.

Conclusions:

  • Calcium is a potent accelerator of alpha-synuclein aggregation across different conditions (surface, solution, cellular).
  • Surface adsorption appears to be a significant factor in the calcium-dependent aggregation mechanism.
  • These findings provide crucial insights into the molecular mechanisms underlying Parkinson's disease pathogenesis.